ASC-US with a positive HPV result means your Pap smear found mildly abnormal cervical cells, and a follow-up test confirmed the presence of a high-risk strain of human papillomavirus. ASC-US stands for “atypical squamous cells of undetermined significance,” which is the mildest abnormality a Pap smear can detect. The combination of these two results typically leads to a closer look at your cervix, but it is not a cancer diagnosis and in most cases does not indicate cancer.
What ASC-US Actually Means
Your cervix is lined with flat cells called squamous cells. During a Pap smear, a sample of these cells is examined under a microscope. When some of them look slightly off but not clearly abnormal, the result is classified as ASC-US. Specifically, the cell nuclei appear about 2.5 to 3 times larger than normal, with mildly irregular features. These changes aren’t dramatic enough to qualify as a definitive precancerous lesion, but they’re unusual enough to flag.
Several things can cause cells to look this way. Yeast infections, general irritation, polyps, and hormonal shifts from pregnancy or menopause can all produce mildly atypical cells on a Pap smear. That’s why an ASC-US result alone doesn’t tell you much. The HPV test is the piece that helps clarify whether the abnormality needs attention.
Why the HPV Result Matters
Not all HPV strains pose a cancer risk. There are over 100 types, and only about a dozen are classified as high-risk. Types 16 and 18 are responsible for the vast majority of cervical cancers. When your HPV test comes back positive, it means one or more high-risk strains were detected in your cervical cells.
High-risk HPV can interfere with the normal life cycle of cervical cells. The virus produces two proteins that disable your cells’ built-in safety mechanisms: one shuts down a protein that normally triggers damaged cells to self-destruct, and the other disables a protein that controls when cells divide. Without those brakes, infected cells can keep multiplying and accumulating genetic errors. Over many years, this can progress from mild changes to moderate dysplasia, severe dysplasia, and eventually cancer. The key word is “years.” This is a slow process, and the vast majority of infections never get that far.
The area most vulnerable to HPV is a specific zone on the cervix where two types of tissue meet. More than 90% of cervical precancers originate at this junction, which is why Pap smears target cells from this region.
How Likely Is This to Be Serious?
The two-year risk of severe precancer or cancer in women with an ASC-US result is roughly 8 to 9%, based on data from a large clinical trial. The prevalence of moderate-to-severe precancerous changes in the broader ASC-US population falls between 5 and 12%. That means the large majority of women with this result do not have a high-grade problem.
For women whose ASC-US is paired with a positive HPV test, the immediate estimated risk of a significant finding is about 4.4%, which is what triggers the recommendation for a closer examination rather than simply waiting. The risk of actual invasive cervical cancer at this stage is low, partly because between one-third and two-thirds of all ASC-US results aren’t even associated with high-risk HPV in the first place. Yours is, which puts you in a group that warrants follow-up, but the odds still strongly favor a benign or low-grade outcome.
What Happens Next
Current guidelines recommend a colposcopy for anyone with an HPV-positive ASC-US result. A colposcopy is essentially a magnified visual exam of your cervix, performed in a clinic much like a Pap smear. Your provider uses a special microscope to look at the cervical surface in detail, usually after applying a dilute vinegar solution that makes abnormal areas temporarily turn white. If any concerning spots appear, a small tissue sample (biopsy) is taken during the same visit. The procedure is brief and may cause mild cramping or a pinching sensation.
If the colposcopy and any biopsies show normal tissue or only low-grade changes, you won’t need immediate treatment. Instead, you’ll return for a follow-up HPV test or co-test (HPV plus Pap) in one year. At that one-year mark, if your HPV test is negative and your Pap is normal, you can return to routine follow-up in another year. The five-year risk of a serious finding after a colposcopy that shows less than moderate precancer is about 3.2%, which is low enough that surveillance alone is appropriate.
If your one-year follow-up still shows a positive HPV result with any cytology abnormality, or a negative HPV result with a more concerning Pap finding, another colposcopy is recommended. This step-by-step approach is designed to catch the small number of cases that progress while avoiding unnecessary procedures for the majority that resolve.
Most HPV Infections Clear on Their Own
Your immune system clears the majority of high-risk HPV infections without any treatment. In studies tracking HPV clearance over time, about 43% of high-risk infections cleared within 6 months and 65% cleared within 18 months in women with normal Pap results. For women who already have mild cell changes (closer to your situation), the clearance rates are somewhat lower: about 29% at 6 months and 41% at 18 months. These numbers reflect clearance of specific HPV types, not just symptom improvement.
The infections that persist for years are the ones that carry real risk. This is why the follow-up schedule matters. It gives your body time to fight the virus while keeping close enough tabs that any progression would be caught early.
How Age Affects Screening and Follow-Up
Screening recommendations differ by age. For women 21 to 29, current guidelines recommend Pap smears alone every three years, without routine HPV testing. HPV is extremely common in this age group, and most infections clear quickly, so routine HPV testing leads to high false-positive rates and unnecessary procedures. If an ASC-US result comes back in this age range, HPV testing may still be used to decide next steps, but the overall approach accounts for the high likelihood of spontaneous clearance.
Starting at age 30, HPV-based screening becomes the primary tool, recommended every five years. At this age, a persistent HPV infection is more clinically meaningful because it’s less likely to be a brand-new, transient infection. This is why an HPV-positive ASC-US result in a woman over 30 is taken seriously from the start, though it still follows the same colposcopy pathway.
What This Result Is Not
An ASC-US HPV-positive result is not a diagnosis of cervical cancer, precancer, or even a confirmed abnormality. It’s a screening signal that places you in a group worth watching more closely. The cells looked slightly unusual, and a virus known to cause cervical problems is present. That combination justifies a closer look, but the most common outcome is either normal findings on colposcopy or low-grade changes that your immune system resolves over the following year or two.